NCT05102669View on ClinicalTrials.gov

Spike-specific Cellular Immune Response After COVID-19 Vaccination

CompletedOBSERVATIONAL
Enrollment

53

Participants

Timeline

Start Date

March 12, 2021

Primary Completion Date

October 1, 2021

Study Completion Date

October 11, 2021

Conditions
COVID19VaccinationImmune Response
Interventions
OTHER

analysis of immunological response

collection and analysis of SARS-CoV2 Spike specific blood cells

DIAGNOSTIC_TEST

analysis of serum antibodies

analysis of anti-SARS-CoV2 Spike specific antibodies

Trial Locations (1)

00163

IRCCS San Raffaele Roma, Roma

All Listed Sponsors
lead

IRCCS San Raffaele Roma

OTHER

NCT05102669 - Spike-specific Cellular Immune Response After COVID-19 Vaccination | Biotech Hunter | Biotech Hunter